Detaylı Arama

İptal
Bulunan: 2 Adet 0.000 sn
- Eklemek veya çıkarmak istediğiniz kriterleriniz için 'VE' / 'VEYA' /'DEĞİL' seçeneğini kullanabilirsiniz.
- İptal tuşuna basarak normal aramaya dönebilirsiniz.
Filtreler
Erişime Açık

First Molecular Evidence for Mycoplasma haemocanis and Candidatus Mycoplasma haematoparvum in Asymptomatic Shelter Dogs in Kyrgyzstan = Kırgızistan’da Asemptomatik Barınak Köpeklerinde Mycoplasma haemocanis ve Candidatus Mycoplasma haematoparvum İçin İlk Moleküler Kanıt

Ayperi Aytmırza Kızı | Zarima CUMAKANOVA | Ayday CUNUŞOVA

Mycoplasma haemocanis (Mhc) and Candidatus Mycoplasma haematoparvum (CMhp) have been investigated using species specific PCR and sequencing in 170 dogs from Kyrgyzstan. Maximum likelihood estimation (MLE) of the infection rates with 95% confidence intervals (CI) was calculated. The molecular prevalence of hemoplasma infection was 5.29% (CI 2.57-9.34). It was found that, five (2.94%, CI 1.06-6.22) samples were found to be infected with Mhc, one (0.59%, CI 0.03-2.57) sample with CMhp and three (1.76%, CI 0.44-4.52) samples with both species. These results demonstrate that dogs can be exposed to ...Daha fazlası

Erişime Açık

First Molecular Detection of Dirofilaria immitis and D. repens in Dogs from Kyrgyzstan

Ayperi Aytmırza Kızı

Background Dirofilaria immitisandDirofilaria repensare the causative agents of cardiopulmonary and subcutaneous dirofilariosis, respectively. This neglected disease mainly seen in dogs, cats and wild carnivores is re-emerging recent years. No study was conducted on dirofilariosis in dogs in Kyrgyzstan. Purpose The goal of this study was to investigateDirofilariaspecies using PCR and sequencing in dogs from Kyrgyzstan. Method Dirofilariaspp. infection in dogs was screened via convential PCR and sequencing in 337 dogs from Kyrgyzstan. Result The overall prevalence ofDirofilariaspp. was 0.59% (2/ ...Daha fazlası

Yükümlülüklerimiz ve çerez politikamız T.C. 6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamındadır.
Tamam

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms